Q4 2025 13F Holders as of 31 Dec 2025
-
Type / Class
-
Debt / NOTE 1.250% 9/1
-
Market price (% of par)
-
89.64%
-
Total 13F principal
-
$147,511,900
-
Principal change
-
-$275,692,130
-
Total reported market value
-
$133,215,981
-
Number of holders
-
18
-
Value change
-
-$243,157,718
-
Number of buys
-
7
-
Number of sells
-
22
Institutional Holders of SAREPTA THERAPEUTICS INC - NOTE 1.250% 9/1 as of Q4 2025
As of 31 Dec 2025,
SAREPTA THERAPEUTICS INC - NOTE 1.250% 9/1 was held by
18 institutional
bondholders
reporting positions in Form 13F filings.
These institutions reported holding
$147,511,900
in principal (par value) of the bond.
The largest 10 bondholders included
HIGHBRIDGE CAPITAL MANAGEMENT LLC, DG Capital Management, LLC, D. E. Shaw & Co., Inc., Calamos Advisors LLC, LMR Partners LLP, ADVENT CAPITAL MANAGEMENT /DE/, BNP PARIBAS ASSET MANAGEMENT Holding S.A., STATE OF WISCONSIN INVESTMENT BOARD, PALISADE CAPITAL MANAGEMENT, LP, and FMR LLC.
This page lists
18
institutional bondholders reporting positions
for the Q4 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price (% of par)
|
Principal |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.